Arrhythmias & electrophysiology

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

EuropacePublished Clinical consensus statement

An erratum to this article was published (Europace, 10 Mar 2026 ↗)

Recommendations

As issued by the authors

  1. ABC framework for AAD therapy: A (Appropriate therapy) where Anti-arrhythmic Drugs (AADs) are the best option; B (Backup therapy) as adjunct to invasive procedures such as catheter ablation; C (Complementary therapy) in combination with other therapies

  2. Pharmacological management remains essential, particularly in patients with cardiac implantable electronic devices or channelopathies, where ablation is often not suitable

  3. Emphasis on pro-arrhythmia risk mitigation

Original publication

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. Europace. Published 30 March 2025. doi:10.1093/europace/euaf076

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.